Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Aeesha Ranavaya"'
Autor:
Benjamin J. Lerman, Yimei Li, Cecilia Carlowicz, Meaghan Granger, Thomas Cash, Arhanti Sadanand, Katherine Somers, Aeesha Ranavaya, Brian D. Weiss, Michelle Choe, Jennifer H. Foster, Navin Pinto, Daniel A. Morgenstern, Margarida Simão Rafael, Keri A. Streby, Rachel N. Zeno, Rajen Mody, Sahr Yazdani, Ami V. Desai, Margaret E. Macy, Suzanne Shusterman, Sara M. Federico, Rochelle Bagatell
Publikováno v:
Journal of Clinical Oncology. 41:508-516
PURPOSE Although chemoimmunotherapy is widely used for treatment of children with relapsed high-risk neuroblastoma (HRNB), little is known about timing, duration, and evolution of response after irinotecan/temozolomide/dinutuximab/granulocyte-macroph
Publikováno v:
Hematology Reports, Vol 11, Iss 1 (2019)
Essential thrombocythemia (ET) is a clonal bone marrow disease, characterized by increased production of platelets along with other clinical and bone marrow findings. Most patients with ET will have a somatic mutation in one of the known gene locatio
Externí odkaz:
https://doaj.org/article/040e4c24edab422181e7ac64673e7201
Publikováno v:
Clinical Pediatrics. 59:736-739
Autor:
Benjamin Lerman, Yimei Li, Meaghan Granger, Thomas Cash, Arhanti Sadanand, Katherine Somers, Aeesha Ranavaya, Michelle Choe, Jennifer Foster, Daniel A. Morgenstern, Margarida Simao Rafael, Keri A. Streby, Rachel Zeno, Rajen Mody, Sahr Yazdani, Ami Vijay Desai, Margaret E Macy, Suzanne Shusterman, Sara Michele Federico, Rochelle Bagatell
Publikováno v:
Journal of Clinical Oncology. 40:10025-10025
10025 Background: Encouraging responses to chemoimmunotherapy with I/T/DIN/GM-CSF have been observed in trials for patients (pts) with relapsed/refractory HR-NBL, but factors associated with response have not been identified and duration of response
Publikováno v:
Hematology Reports
Hematology Reports, Vol 11, Iss 1 (2019)
Hematology Reports, Vol 11, Iss 1 (2019)
Essential thrombocythemia (ET) is a clonal bone marrow disease, characterized by increased production of platelets along with other clinical and bone marrow findings. Most patients with ET will have a somatic mutation in one of the known gene locatio
Publikováno v:
Hematology Reports. 2019, Vol. 11 Issue 1, p12-15. 4p.
Publikováno v:
Clinical Pediatrics; Jun2020, Vol. 59 Issue 7, p736-739, 4p